ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 59 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $195 | -69.1% | 122,676 | -86.1% | 0.02% | -69.4% |
| Q1 2023 | $631 | +31.2% | 879,684 | +5.9% | 0.06% | +3.3% |
| Q4 2022 | $481 | -99.4% | 830,829 | +950.7% | 0.06% | +500.0% |
| Q3 2022 | $75,000 | -85.5% | 79,076 | -80.0% | 0.01% | -85.7% |
| Q1 2022 | $518,000 | -43.6% | 395,585 | -24.3% | 0.07% | -39.1% |
| Q4 2021 | $919,000 | +665.8% | 522,284 | +4378.9% | 0.12% | +475.0% |
| Q3 2020 | $120,000 | -36.2% | 11,661 | -28.4% | 0.02% | -9.1% |
| Q4 2019 | $188,000 | +108.9% | 16,278 | +10.0% | 0.02% | +340.0% |
| Q3 2018 | $90,000 | – | 14,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |